NOTCH1 and B-cell chronic lymphocytic leukemia: The development of NOTCH1 inhibitors and γ-secretase inhibitors as potential therapeutic strategies is an active area of research, aiming to counteract the oncogenic effects of NOTCH1 activation in CLL [189].